Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Therapeutic Drug Carrier Systems
Factor de Impacto: 2.9 Factor de Impacto de 5 años: 3.72 SJR: 0.573 SNIP: 0.551 CiteScore™: 2.43

ISSN Imprimir: 0743-4863
ISSN En Línea: 2162-660X

Volumes:
Volumen 36, 2019 Volumen 35, 2018 Volumen 34, 2017 Volumen 33, 2016 Volumen 32, 2015 Volumen 31, 2014 Volumen 30, 2013 Volumen 29, 2012 Volumen 28, 2011 Volumen 27, 2010 Volumen 26, 2009 Volumen 25, 2008 Volumen 24, 2007 Volumen 23, 2006 Volumen 22, 2005 Volumen 21, 2004 Volumen 20, 2003 Volumen 19, 2002 Volumen 18, 2001 Volumen 17, 2000 Volumen 16, 1999 Volumen 15, 1998 Volumen 14, 1997 Volumen 13, 1996 Volumen 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v16.i5.20
62 pages

Microemulsions: An Overview and Pharmaceutical Applications

Srini Tenjarla
Associate Director, Shire Pharmaceutical Development Inc, 1901, Research Boulevard, Suite 500, Rockville, MD 20850; and Serquest, a Southern Research Institute Company, 2000 Ninth Avenue South, Birmingham, AL 35205, USA

SINOPSIS

Microemulsions are potential drug carrier systems for oral, topical, and parenteral administration. They offer the advantage of spontaneous formation, ease of manufacturing and scale-up, thermodynamic stability, and improved drug solubilization and bioavailability. Preparing a pharmaceutically acceptable dosage form demands a clear understanding of the micro-emulsion structure, phase behavior, factors leading to its thermodynamic stability, factors influencing drug release from the formulation, requirements of ideal microemulsion excipients, and the potential uses and limitations of the microemulsion system. Knowledge of the various methods available to thoroughly characterize a microemulsion system is essential. An overview of these factors is presented in this review. While microemulsion is used in several fields, in this review the pharmaceutical applications are emphasized. Several references are cited, but the list is by no means exhaustive. The review is written so that a newcomer to the field can easily grasp the important facts pertaining to this novel delivery system.


Articles with similar content:

Oral Colon-Specific Drug Delivery of Protein and Peptide Drugs
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.24, 2007, issue 1
Ruchita V. Kumar, Sanjay Singh, Vivek Ranjan Sinha, J. R. Bhinge, Asmita Singh, Rachana Kumria
Emerging Potential of Nanosuspension-Enabled Drug Delivery: An Overview
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.32, 2015, issue 6
Vivek Ranjan Sinha, Silki
Improved Drug Delivery Using Microemulsions: Rationale, Recent Progress, and New Horizons
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.18, 2001, issue 1
J. R. Kanicky, D. O. Shah, P. K. Patanjali, B. J. Palla, R. P. Bagwe
Inflammatory Bowel Disease: Pathogenesis, Causative Factors, Issues, Drug Treatment Strategies, and Delivery Approaches
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.32, 2015, issue 3
Shikha Srivastava, Madhulika Pradhan, Deependra Singh, Manju Rawat Singh, Jagat R. Kanwar
A Review of the Application of Lipid-Based Systems in Systemic, Dermal/ Transdermal, and Ocular Drug Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.25, 2008, issue 6
Kishor M. Wasan, Pavel Gershkovich, Cheri A. Barta